Therapeutic potential of eucommia in chronic metabolic diseases: phytochemical basis, pharmacological actions, and molecular mechanisms
Abstract
Chronic metabolic diseases, mainly including obesity, diabetes mellitus, hyperlipidemia, and metabolic dysfunction-associated steatotic liver disease, are characterized by disorders of glucose and lipid metabolism, abnormal energy homeostasis, chronic low-grade inflammation, and multi-organ dysfunction. With the increasing global burden of these diseases, natural medicines and medicine–food homology resources with potential metabolic regulatory properties have attracted growing attention, although their long-term efficacy and safety require further investigation. Eucommia ulmoides Oliver (Eucommiaceae), hereafter referred to as Eucommia, is a traditional tonic herb in China and has long been used to tonify the liver and kidney and strengthen bones and muscles. Its medicinal bark (Eucommia Cortex), leaves (Eucommia Folium), flowers, and seeds contain diverse bioactive constituents, including iridoids, phenolic acids, flavonoids, lignans, terpenoids, and polysaccharides. Preclinical studies suggest that Eucommia and its bioactive constituents may exert beneficial effects on metabolic abnormalities through several potential mechanisms, including the regulation of fatty acid oxidation, lipid synthesis, insulin resistance, gut microbiota and microbial metabolites, bile acid metabolism, oxidative stress, inflammation, and autophagy, as well as potential protective effects on metabolism-related organs. However, these findings require further validation in human studies. This narrative review summarizes the phytochemical basis, reported pharmacological activities, and proposed molecular mechanisms of Eucommia in chronic metabolic diseases, and discusses the potential of its Folium as a renewable complementary resource, while critically considering the limitations of current evidence regarding clinical efficacy, long-term safety, and environmental and economic sustainability.
Related
- Pigeonpea leaves in orthopedic diseases: bioactive metabolites, pharmacological actions and therapeutic potential
- Exerkines in Cardiovascular–Kidney–Metabolic Syndrome: An Integrative Framework for Mechanisms and Therapeutic Implications—A Narrative Review
- Thioredoxin system: mechanisms and therapeutic potential in mental disorders
- Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
- Shared mechanisms and therapeutic horizons: exploring the potential interplay between benign prostatic hyperplasia/lower urinary tract symptoms and Alzheimer’s disease
BibTeX
@article{wang2026therapeutic,
title = {{Therapeutic potential of eucommia in chronic metabolic diseases: phytochemical basis, pharmacological actions, and molecular mechanisms}},
author = {Zhineng Wang and Huichun Xie and Xiaomei Zhang and Tingzhen Wei and Wancai Zheng},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.2009669},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.2009669},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Therapeutic potential of eucommia in chronic metabolic diseases: phytochemical basis, pharmacological actions, and molecular mechanisms
AU - Zhineng Wang
AU - Huichun Xie
AU - Xiaomei Zhang
AU - Tingzhen Wei
AU - Wancai Zheng
PY - 2026
DA - 2026/11/03
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.2009669
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.2009669
AB - Chronic metabolic diseases, mainly including obesity, diabetes mellitus, hyperlipidemia, and metabolic dysfunction-associated steatotic liver disease, are characterized by disorders of glucose and lipid metabolism, abnormal energy homeostasis, chronic low-grade inflammation, and multi-organ dysfunction. With the increasing global burden of these diseases, natural medicines and medicine–food homology resources with potential metabolic regulatory properties have attracted growing attention, although their long-term efficacy and safety require further investigation. Eucommia ulmoides Oliver (Eucommiaceae), hereafter referred to as Eucommia, is a traditional tonic herb in China and has long been used to tonify the liver and kidney and strengthen bones and muscles. Its medicinal bark (Eucommia Cortex), leaves (Eucommia Folium), flowers, and seeds contain diverse bioactive constituents, including iridoids, phenolic acids, flavonoids, lignans, terpenoids, and polysaccharides. Preclinical studies suggest that Eucommia and its bioactive constituents may exert beneficial effects on metabolic abnormalities through several potential mechanisms, including the regulation of fatty acid oxidation, lipid synthesis, insulin resistance, gut microbiota and microbial metabolites, bile acid metabolism, oxidative stress, inflammation, and autophagy, as well as potential protective effects on metabolism-related organs. However, these findings require further validation in human studies. This narrative review summarizes the phytochemical basis, reported pharmacological activities, and proposed molecular mechanisms of Eucommia in chronic metabolic diseases, and discusses the potential of its Folium as a renewable complementary resource, while critically considering the limitations of current evidence regarding clinical efficacy, long-term safety, and environmental and economic sustainability.
SN - 1663-9812
ER -